Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05762445 · ClinicalTrials.gov registry record
PAtient-CenTric Chronic Pancreatitis Registry (PACT-CP)
A clinical trial, sponsored by CorEvitas.
- Completed
- Registry status
- 400
- Enrollment target
NCT05762445: Completed study, sponsored by CorEvitas.
NCT05762445 is a clinical trial that has completed, run by CorEvitas. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05762445 has completed, sponsored by CorEvitas.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The main objective of this study is to generate real-world evidence reflecting the experience of individuals with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP). Efforts will be directed toward understanding the unmet need and therapeutic burden to identify the most critical factors that influence treatment choices/prescribing patterns, quality of life, and healthcare utilization outcomes in standard of care for individuals with EPI due to CP.
Primary Outcome
The main objective of this study is real-world evidence reflecting the experience of individuals with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-06-02 |
| Est. Completion | 2025-08-31 |
What the finished NCT05762445 record still lists
NCT05762445 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05762445 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05762445 about?
NCT05762445 is a clinical study titled "PAtient-CenTric Chronic Pancreatitis Registry (PACT-CP)". The main objective of this study is to generate real-world evidence reflecting the experience of individuals with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP). Efforts will be directed toward understanding the unmet need and therapeutic burden to identify the most critica...
What is the current status of trial NCT05762445?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2021-06-02. Estimated completion is 2025-08-31.
Who is sponsoring clinical trial NCT05762445?
This trial is sponsored by CorEvitas, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI